Video - Miscellaneous protein synthesis inhibitors
00:00 / 00:00
More Videos
04:07
Mechanisms of antibiotic resistance
10:46
Antimetabolites: Sulfonamides and trimethoprim
14:06
Antituberculosis medications
15:07
Cell wall synthesis inhibitors: Cephalosporins
13:49
Cell wall synthesis inhibitors: Penicillins
07:11
DNA synthesis inhibitors: Fluoroquinolones
05:24
DNA synthesis inhibitors: Metronidazole
15:09
Miscellaneous cell wall synthesis inhibitors
15:19
Miscellaneous protein synthesis inhibitors
11:25
Protein synthesis inhibitors: Aminoglycosides
10:45
Protein synthesis inhibitors: Tetracyclines
Video Summary
Protein synthesis inhibitors are a class of antibiotics which prevent bacterial ribosomes from synthesizing proteins. They include drugs like chloramphenicol, macrolides, lincosamides, and oxazolidinones.
Most of these drugs act on the 50S subunit of the ribosome, but their mechanisms can be very different. For example, oxazolidinones like linezolid stop the initiation complex from forming. Both the macrolides and lincosamides prevent translocation. Chloramphenicol inhibits peptidyl transferase which is the enzyme that creates the peptide bonds.
For Institutions
Copyright © 2024 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.
